Demerger23 Jun 2021 12:44
Have I read it correctly that existing shareholders will hold some of the new business, while the remainder will be listed on the exchange?
"Subject to approval from shareholders, the separation will be by way of a demerger of at least 80% of GSK's 68% holding in the Consumer Healthcare business to GSK shareholders, with the new Consumer Healthcare company shares expected to attain a premium listing on the London Stock Exchange, with ADRs to be listed in the US."